LINC00893 and its downstream molecules miR-146b-3p and PRSS8 may serve as novel biomarkers and therapeutic targets of colon cancer, providing new treatment options and research approaches towards colon cancer. This evidence concerns the gene EOLA1-DT and malignant colon neoplasm.